Myeloperoxidase in the neurodegenerative process of Parkinson's disease

被引：15
|
作者：
Teismann, P. [1 ]
机构：
[1] Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2014年 / 139卷 / 03期
关键词：
myeloperoxidase; Parkinson's disease; MPTP; neutrophils; Aastrocytes; gliosis; neurodegeneration; OXIDATIVE STRESS; MODEL; ACTIVATION; MICE;
D O I：
10.1055/s-0033-1359907
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Myeloperoxidase (MPO) is a hemoprotein which is involved in the unspecific immune response. In this process hypochloric acid is released. Hypochloric acid can react with lipids and proteins and thus lead to cell damage. We were able to show that MPO, as well as a biomarker for MPO - 3-Chlorotyrosine - are upregulated in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-model of Parkinson's disease as well as in the disease itself. Ablation of MPO resulted in a neuroprotective effect in the MPTP-model. Herein we describe the different function of MPO, and how these can lead to the cellular demise as seen in Parkinson's disease.
引用
收藏
页码：99 / 102
页数：4
相关论文
共 50 条
  • [1] The role of amylin in Parkinson′s disease neurodegenerative process
    Bugallo, R.
    Martinez-Valbuena, I.
    Marcilla, I.
    Caballero, M. C.
    Vilas-Zornoza, A.
    Guruceaga, E.
    Sanchez-Arias, A.
    Ursua, S.
    Perez-Mediavilla, A.
    Luquin, M. R.
    MOVEMENT DISORDERS, 2021, 36 : S330 - S331
  • [2] COX-2 in the neurodegenerative process of Parkinson's disease
    Teismann, Peter
    BIOFACTORS, 2012, 38 (06) : 395 - 397
  • [3] Possible Neurophysiological Markers of Early Neurodegenerative Process: Parkinson’s Disease
    B. Kh. Baziyan
    Bulletin of Experimental Biology and Medicine, 2012, 154 : 186 - 188
  • [4] Possible Neurophysiological Markers of Early Neurodegenerative Process: Parkinson's Disease
    Baziyan, B. Kh.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 154 (02) : 186 - 188
  • [5] Morphometric Parameters of the Neurodegenerative Process in Parkinson’s Disease and Chronic Cerebral Ischemia
    Bogdanov R.R.
    Manannikova E.I.
    Abramenko A.S.
    Maratkanova T.V.
    Kotov S.V.
    Neuroscience and Behavioral Physiology, 2015, 45 (3) : 327 - 331
  • [6] Morphometric parameters of the neurodegenerative process in Parkinson's disease and chronic cerebral ischemia
    Bogdanov, R. R.
    Manannikova, E. I.
    Abramenko, A. S.
    Maratkanova, T. V.
    Kotov, S. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (10) : 40 - 44
  • [7] Neurodegenerative disorders: Parkinson's disease and Huntington's disease
    Hague, SM
    Klaffke, S
    Bandmann, O
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (08): : 1058 - 1063
  • [8] Neurodegenerative disease: New leads for Parkinson's disease
    Kingwell K.
    Nature Reviews Neuroscience, 2010, 11 (10) : 666 - 667
  • [9] Parkinson's disease -: a multifactorial neurodegenerative disorder
    Riess, O
    Krüger, R
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (56): : 113 - 125
  • [10] Neurodegenerative disease: Pieces of the Parkinson's puzzle
    Ozawa Y.
    Nature Reviews Neuroscience, 2010, 11 (12) : 787 - 787
12345